Our research is focused on understanding how the infectious agent-specific antibody repertoire in circulation and mucosal sites develop in response to various diseases and exposures, applying this knowledge to engineer personalized vaccines and immunotherapies. By developing and implementing innovative high-throughput technologies, big data analytics tools, proteomic analytical methods, and data modeling tools, the group aims to gain clinically relevant insights regarding the precise protective features of antibodies and their protective mechanisms at unprecedented details.